The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: A relation with coronary angiography results

Kardiologia Polska

Volumn 63, Issue 2, 2005, Pages 107-114

  Lewandowski, Krzysztof ^a   Świerczyńska, Anna ^b   Kwaśnikowski, Piotr ^b   Elikowski, Waldemar ^c,d   Rzeźniczak, Mirosław ^c,d   Dzida, Grzegorz ^e  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^c Jozef Strus Hospital   (Poland)

^d Oddzial Kardiochirurgii   (Poland)

^e MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

C807T polymorphism of the GPIa gene; Coronary angiography; Myocardial infarction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; SMOKING;

EID: 24744460505     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Reiner AP, Schwartz SM, Kumar PN, et al. Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Haematol 2001; 112: 632-6.
2. Hato T, Minamoto Y, Fukuyama T, et al. Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 1997; 80: 1222-4.
3. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, P1A1 and P1A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-81.
4. Santoso S, Kunicki TJ, Kroll H, et al. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449-53.
5. Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999; 353: 351-4.
6. Cambria-Kiely JA, Gandhi PJ. Aspirin resistance and genetic polymorphisms. J Thromb Thrombolysis 2002; 14: 51-8.
7. Lewandowski K, Kwaśnikowski P, Elikowski W, et al. Czȩstość nosicielstwa skojarzonych defektów prozakrzepowych u pacjentów po zawale serca przebytym przed 40. rokiem życia. Pol Arch Med Wewn 2001; CV: 97.
8. Lewandowski K, Kwaśnikowski P, Elikowski W, et al. Nosicielstwo polimorfizmu Bcl/genu łańcucha β-fibrynogenu a stȩżenie fibrynogenu we krwi u chorych po zawale serca przebytym przed 40. rokiem życia. Kardiol Pol 2003; 59: 209-12.
9. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001; 87: 1361-6.
10. Russo C, Girelli D, Olivieri O, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001; 103: 2436-40.
11. Nakai K, Itoh C, Nakai K, et al. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs 2001; 1: 353-61.
12. Retterstol L, Paus B, Bohn M, et al. Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. J Intern Med 2003; 253: 284-92.
13. Cadroy Y, Sakariassen KS, Charlet JP, et al. Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 2001; 98: 3159-61.
14. 2 gene coding sequence. Blood 1997; 89: 1939-43.
15. 1 density. Blood 1998; 92: 2382-8.
16. von Beckerath N, Koch W, Mehilli J, et al. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 2000; 95: 3297-301.
17. Benze G, Heinrich J, Schulte H, et al. Association of the GPIa C807T and GPIIIa P1A1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 2002; 23: 325-30.
18. Inbal A, Freimark D, Modan B, et al. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999; 93: 2186-90.
19. Hessner MJ, Dinauer DM, Kwiatkowski R, et al. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. Clin Chem 2001; 47: 1879-84.